Literature DB >> 25405093

Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes.

Antonella Mameli1, Francesco Marongiu1.   

Abstract

The risk of venous thromboembolism (VTE) in rheumatoid arthritis (RA) and the higher incidence of RA patients undergoing major orthopedic surgery is well recognized. The objective of the present study is to describe the incidence of VTE and discuss the correct prophylaxis in RA patients undergoing knee or hip replacement. A systematic review of studies on thromboprophylaxis in RA patients undergoing major orthopedic surgery was performed. Detailed information was extracted to calculate the rate of VTE in RA orthopedic patients and analyze the thromboprophylaxis performed and bleeding complications. Eight articles were eligible for full review. No difference in the overall rate of VTE was observed between RA patients and controls. No significant differences were found in RA patients in terms of bleeding complications. The data on the optimal prophylaxis to be used in RA patients were insufficient to recommend any of the several options available. In the absence of dedicated guidelines for the care of RA patients undergoing orthopedic surgery, management must be individualized to obtain favorable patient outcome, weighing up all the factors that might put the patient at risk for higher bleeding and thrombotic events.

Entities:  

Keywords:  Orthopaedic surgery; Rheumatoid arthritis; Thromboprophylaxis; Total hip arthroplasty; Total knee arthroplasty

Year:  2014        PMID: 25405093      PMCID: PMC4133472          DOI: 10.5312/wjo.v5.i5.645

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  30 in total

Review 1.  Surgery of the rheumatoid knee.

Authors:  P J Abernethy
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

Review 2.  Surgical treatment of the rheumatoid hip.

Authors:  I G Kelly
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

3.  Prevention of thrombosis after hip arthroplasty. A prospective study of preoperative oral anticoagulants.

Authors:  B A Swierstra; J Stibbe; H J Schouten
Journal:  Acta Orthop Scand       Date:  1988-04

Review 4.  Venous thromboembolic disease.

Authors:  R D Hull; G E Raskob
Journal:  Curr Opin Cardiol       Date:  1991-10       Impact factor: 2.161

Review 5.  New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Authors:  Francesco Scaglione
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

6.  Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.

Authors:  R D Hull; G E Raskob; M Gent; D McLoughlin; D Julian; F C Smith; N I Dale; R Reed-Davis; R N Lofthouse; C Anderson
Journal:  JAMA       Date:  1990-05-02       Impact factor: 56.272

Review 7.  Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery.

Authors:  R D Hull; G F Pineo; S MacIsaac
Journal:  Thromb Res       Date:  2001-01-01       Impact factor: 3.944

8.  Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.

Authors:  Yuichi Nagase; Hideo Yasunaga; Hiromasa Horiguchi; Hideki Hashimoto; Naoko Shoda; Yuho Kadono; Shinya Matsuda; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

9.  Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.

Authors:  Wei-Sheng Chung; Chiao-Ling Peng; Cheng-Li Lin; Yen-Jung Chang; Yung-Fu Chen; John Y Chiang; Fung-Chang Sung; Chia-Hung Kao
Journal:  Ann Rheum Dis       Date:  2013-08-07       Impact factor: 19.103

10.  Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants.

Authors:  Carsten Perka
Journal:  Thromb J       Date:  2011-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.